CyPass recall tops 2018 glaucoma news

Alcon called for a voluntary withdraw of its CyPass micro-stent in August after data found significant endothelial cell loss 5 years after implantation. The news was the most-read glaucoma-related article on Healio.com/OSN in 2018.
Here are the top five glaucoma stories of the year:
 
Alcon calls for surgeons to stop implanting CyPass micro-stent
Citing “uncompromising commitment to patient safety,” Alcon has announced an immediate, voluntary withdrawal of all versions of the CyPass micro-stent from the global market and advises surgeons to immediately cease further implantation

Full Story →